Skip to content

Clinical trials

Active, not recruiting Multiple Myeloma trials in the United States

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Multiple Myeloma Status: Active, not recruiting Country / region: United States Clear all

213 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20041
20062
20083
20093
20103
20111
20123
20131
201511
201619
201714
201811
201923
202022
202120
202229
202323
202416
20254
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Active, not recruiting213

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
National Cancer Institute (NCI)37
Memorial Sloan Kettering Cancer Center18
Janssen Research & Development, LLC16
AbbVie9
GlaxoSmithKline9
M.D. Anderson Cancer Center7
Massachusetts General Hospital6
Mayo Clinic5
Bristol-Myers Squibb4
Celgene4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Multiple Myeloma213
Lymphoma41
Hematologic Neoplasms21
Recurrence18
Lymphoma, Non-Hodgkin13
Neoplasms, Plasma Cell13
Hodgkin Disease9
Myelodysplastic Syndromes9
Leukemia8
Leukemia, Myeloid, Acute8

Trials

Showing 1 to 25 of 213. Each trial links to its page on Pharma Observatory.

113 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.